Description

This issue of Vital Signs, released on March 16, 2009, provides a strategic overview of the adoption of image fusion software possibly surpassing MR/PET, and which sectors offer alternative growth opportunities for MR/PET. Additionally, a company spotlight is provided for Serica Technologies, Inc., a company developing silk-based biomaterial platforms that may be used for tissue repair and regeneration applications in orthopedics and sports medicine. Reimbursement and regulatory news from the FDA is also provided for the week of March 2, 2009.